- Home
- FTLF vs MIST Comparison
FTLF vs MIST Comparison
Compare FTLF & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTLF | MIST |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.6M | 176.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FTLF | MIST |
|---|---|---|
| Price | $15.41 | $2.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $23.00 | $8.50 |
| AVG Volume (30 Days) | 14.2K | ★ 9.9M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $70,561,000.00 | N/A |
| Revenue This Year | $32.74 | N/A |
| Revenue Next Year | $50.36 | N/A |
| P/E Ratio | $22.82 | ★ N/A |
| Revenue Growth | ★ 12.44 | N/A |
| 52 Week Low | $9.83 | $0.63 |
| 52 Week High | $20.98 | $3.06 |
Technical Indicators
Market Signals| Indicator | FTLF | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 37.00 | 50.19 |
| Support Level | $15.51 | $1.98 |
| Resistance Level | $16.68 | $2.10 |
| Average True Range (ATR) | 0.75 | 0.13 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 7.39 | 76.98 |
Price Performance
Historical ComparisonAbout FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).